1. National Cancer Institute. The surveillance, epidemiology, and end results stat fact sheets: prostate cancer. http://seer.cancer.gov/statfacts/html/prost.html . Accessed 3 Jul 2015.
2. American Cancer Society. Prostate cancer. http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate-cancer-key-statistics . Accessed 3 Jul 2015.
3. Vasani D, Josephson DY, Carmichael C, Sartor O, Pal SK. Recent advances in the therapy of castration-resistant prostate cancer: the price of progress. Maturitas. 2011;70(2):194–6.
4. Package insert and patient information—Provenge. US Food and Drug Administration. 2010. http://www.fda.gov/downloads/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/UCM210031.pdf . Accessed 10 Sep 2015.
5. Provenge. Approval History. US Food and Drug Administration. 2007. http://www.fda.gov/BiologicsBloodVaccines/CellularGeneTherapyProducts/ApprovedProducts/ucm213554.htm . Accessed 3 Jul 2015.